Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Leveraging AI to Improve Patient Outcomes in Healthcare

The importance of providing patients with a fast and accurate diagnosis cannot be overstated – it can be the difference between life and death. Unfortunately, the healthcare system is overwhelmed, and physicians cannot keep up with the overflow of patient needs in a timely manner. Dr. Chai Xiangfei, CEO and co-founder at HY Medical, and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The importance of providing patients with a fast and accurate diagnosis cannot be overstated – it can be the difference between life and death. Unfortunately, the healthcare system is overwhelmed, and physicians cannot keep up with the overflow of patient needs in a timely manner.

Dr. Chai Xiangfei, CEO and co-founder at HY Medical, and Beenish Zia, chief architect of medical imaging at Intel, sit down with podcast host, Tyler Kern, to discuss the current challenges of providing a patient diagnosis in a timely manner and how artificial intelligence (AI) solutions can help.

Beenish discusses and highlights the complexities of diagnosing patient illnesses. “Medical diagnosis is a complex process which requires clinical skills and the need for clear decisions. And it needs to be balanced with acceptance for the ambiguity of many clinical situations,” Beenish explains.

According to Beenish, there are five major obstacles that delay diagnosis:

  1. There are variations in individual logic and processes.
  2. Because the nature of the evidence is not clear, further tests/screenings are required.
  3. Standards vary globally, which causes longer diagnosis times.
  4. Lack of evidence and data from diverse populations leads to not having good data sets to represent different communities.
  5. The number of cases a physician must handle grows daily.

“For example, in certain hospitals in New York, we have heard that the radiologists get more than 1400 scans per day, and maybe there is just like a handful of radiologists to look at them. So, just the huge imbalance between the number of cases requiring diagnosis and the medical staff available to provide the diagnosis is not good,” Beenish explains.

To address this need, Dr. Chai talks about the role of AI in reducing diagnosis time to improve patient outcomes. “There are a huge amount of images created every day. In the meantime, actually, there’s a shortage of radiologists to read images. So, the real situation is that because there is a long waiting list of imaging… it can take hours or even days” for patients to get the result of their tests, notes Dr. Chai.

With traditional processes, scans are taken and added to a waiting list to be read and interpreted by radiologists, which can take up to 15 minutes. Current AI technology can give initial results within one minute and can ultimately reduce reading time by 30%. When radiology staff and doctors get the initial results, they can then quickly review the areas highlighted by the AI and then determine a path forward for diagnosis and treatments. Having this reduction in reading time, is helping patients get treated sooner.

To learn more about how AI can transform the diagnostic process and improve patient outcomes, connect with Dr. Chai Xiangfei and Beenish Zia on LinkedIn.

To find out more about HY Medical please visit: https://www.huiyihuiying.com/#page1.

Learn about various technologies Intel offers to advance the healthcare field — from compute to storage and networking to AI — visit: https://www.intel.com/content/www/us/en/healthcare-it/healthcare-overview.html

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Internet of Things Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz brings 23+ years of experience as chief medical physicist at Texas Oncology and personal insight as a breast cancer survivor, enabling her to guide patient support groups and advocate for accessible cancer care. She emphasizes AI's potential in auto-contouring and treatment planning while stressing the need for proper training, validation, and transparency before implementation.

  • 01Over 23 years at Texas Oncology integrating personal cancer survivor experience with clinical expertise to improve patient empathy and support group leadership
  • 02AI in oncology requires human oversight, validation, and transparency; auto-contouring and auto-planning must be combined with staff training and rigorous protocol testing before deployment
  • 03Texas Oncology prioritizes offering state-of-the-art cancer treatments closer to home, including for rural patients, to reduce travel and ensure consistent, personalized care

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512